Patent Assignment
Reel/Frame 069109/0896
Assignment of Assignor's Interest
Recorded: 2024-11-01
Pages: 5
Assignor
ZAMBONI, ROBERT
Executed: 2024-10-25
Assignee
BRIDGEBIO PHARMA CANADA, ULC
4915 OLIVIA PLACE, MONTREAL, HR4 2V6, CANADA
Covered Property
(1)
A1AT Modulators
Application:
63/593,681 →
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest
Aug 16, 2024
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: PORTAL THERAPEUTICS, INC.; SUB21, INC.; BRIDGEBIO PHARMA, INC.
Reel/Frame 068317/0804 →
Assignment of Assignor's Interest
Nov 1, 2024
From: AKBARIROMANI, ELHAM; DIAS, DWAYNE ANTHONY; GAO, DI; GERANURIMI, AZADE
To: ZAMBONI CHEM SOLUTIONS INC.
Reel/Frame 069109/0368 →
Assignment of Assignor's Interest
Nov 1, 2024
From: ZAMBONI CHEM SOLUTIONS INC.
To: SUB21, INC.
Reel/Frame 069109/0681 →
Assignment of Assignor's Interest
Nov 1, 2024
From: BRIDGEBIO PHARMA CANADA, ULC
To: SUB21, INC.
Reel/Frame 069110/0062 →